Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.

Back

ESC Professional Premium Access

Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.

Session: The growing importance of phenotyping in heart failure

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor A. Minervini (Bologna, IT)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Annamaria Minervini

University Hospital of Bologna S. Orsola-Malpighi Polyclinic, Bologna (Italy)

1 presentation

0 follower

5 more presentations in this session

Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study

Speaker: Professor P. Garcia-Pavia (Majadahonda, ES)

Associations of fasting state glycemic biomarkers with mortality and morbidity in heart failure: Retrospective cohort study

Speaker: Doctor K. Iwasaki (Okayama, JP)

Usefulness of a scoring evaluation for practical introduction of the guideline-directed medical therapy (GDMT) in heart failure patients

Speaker: Doctor R. Matsukawa (Fukuoka, JP)

Level of education and mortality in the vulnerable period following an acute heart failure hospitalization

Speaker: Doctor G. Pereira Da Cunha (Curitiba, BR)

Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure

Speaker: Doctor A. Toste (Porto, PT)

Access the full session

The growing importance of phenotyping in heart failure

Speakers: Doctor A. Minervini, Professor P. Garcia-Pavia, Doctor K. Iwasaki, Doctor R. Matsukawa, Doctor G. Pereira Da Cunha...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.

About the speaker

Doctor Annamaria Minervini

5 more presentations in this session

Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study

Associations of fasting state glycemic biomarkers with mortality and morbidity in heart failure: Retrospective cohort study

Usefulness of a scoring evaluation for practical introduction of the guideline-directed medical therapy (GDMT) in heart failure patients

Level of education and mortality in the vulnerable period following an acute heart failure hospitalization

Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure

Access the full session

The growing importance of phenotyping in heart failure

About the event

ESC Congress 2023

ESC 365 is supported by